Parabilis Medicines, Inc. (PBLS) stock
PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$28.47+0.22 (+0.78%)
Close on Nov 18, 2026Market cap $3.52BP/E –Yield –
Parabilis Medicines revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $148.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
See a number that looks wrong?